P14.124 EORTC 1709/CCTG CE.8: A phase III trial of...

Neuro-Oncology 2019 / 09 Vol. 21; Iss. Supplement

P14.124 EORTC 1709/CCTG CE.8: A phase III trial of marizomib in combination with standard temozolomide-based radiochemotherapy versus standard temozolomide-based radiochemotherapy alone in patients with newly diagnosed glioblastoma

Roth, P, Reijneveld, J, Gorlia, T, Dhermain, F, De Vos, F, Vanlancker, M, O’Callaghan, C, Le Rhun, E, van den Bent, M, Mason, W, Weller, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noz126.359
Date:
September, 2019
File:
PDF, 86 KB
2019
Conversion to is in progress
Conversion to is failed